TNFSF11 Biosimilar Antibody
TNFSF11 Biosimilar Antibody
Product Specifications
Product Name Alternative
Fresenius Kabi Pharmaceuticals Holding LLC research-grade biosimilar; Bomyntra research-grade biosimilar; Conexxence research-grade biosimilar; denosumab research-grade biosimilar; Denosumab Biosimilar (Fresenius Kabi Pharmaceuticals Holding LLC) research-grade biosimilar; FKS518 research-grade biosimilar ; TNFSF11 antibody; OPGL antibody; RANKL antibody; TRANCE antibody; Tumor necrosis factor ligand superfamily member 11 antibody; Osteoclast differentiation factor antibody; ODF antibody; Osteoprotegerin ligand antibody; OPGL antibody; Receptor activator of nuclear factor kappa-B ligand antibody; RANKL antibody; TNF-related activation-induced cytokine antibody; TRANCE antibody; CD antigen CD254 [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form antibody; Tumor necrosis factor ligand superfamily member 11, soluble form] antibody
UniProt
O14788
Reactivity
Human
Immunogen
Recombinant Human TNFSF11 protein
Target
TNFSF11
Clonality
Monoclonal
Conjugation
Unconjugated
Purity
> 95% tested by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Preservative
0.01M PBS, pH 7.4
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
